Page last updated: 2024-10-28

phenelzine and Atherosclerotic Parkinsonism

phenelzine has been researched along with Atherosclerotic Parkinsonism in 4 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teusink, JP1
Alexopoulos, GS1
Shamoian, CA1
Gillman, MA1
Sandyk, R1
Patni, SK1
Dandiya, PC2
Bhargava, LP1

Other Studies

4 other studies available for phenelzine and Atherosclerotic Parkinsonism

ArticleYear
Parkinsonian side effects induced by a monoamine oxidase inhibitor.
    The American journal of psychiatry, 1984, Volume: 141, Issue:1

    Topics: Aged; Depressive Disorder; Female; Humans; Parkinson Disease, Secondary; Phenelzine

1984
Parkinsonism induced by a monoamine oxidase inhibitor.
    Postgraduate medical journal, 1986, Volume: 62, Issue:725

    Topics: Adult; Female; Humans; Parkinson Disease, Secondary; Phenelzine

1986
The influence of monoamine oxidase inhibitors and some other antidepressants on the anti-parkinsonian activity of sub-effective doses of diphenylhydramine in rats and mice.
    Japanese journal of pharmacology, 1972, Volume: 22, Issue:3

    Topics: Animals; Antidepressive Agents; Catatonia; Diphenhydramine; Humans; Mice; Monoamine Oxidase Inhibito

1972
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Archives internationales de pharmacodynamie et de therapie, 1968, Volume: 176, Issue:1

    Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine

1968